Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025. - Patton ME; Moline HL; Whitaker M; Tannis A; Pham H; Toepfer AP; Taylor CA; Goldstein L; Reingold A; Kirley PD; Alden NB; Kawasaki B; et al. (MMWR. Morbidity and mortality weekly report, 2025)